Iovance Biotherapeutics, Inc.(IOVA)
Biotechnology
Cell Therapy (CAR-T, etc.)
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-06-06 | Kirby Daniel Gordon Chief Commercial Officer | Purchase | +30,000 | +100.00%30,000 | $1.84 | $55,200 | View SEC filing | |
| 2025-05-27 | Puri Raj K. Chief Regulatory Officer | Purchase | +5,600 | +2.78%206,852 | $1.74 | $9,743 | View SEC filing | |
| 2025-05-16 | Vogt Frederick G Interim CEO & General Counsel | Purchase | +25,000 | +7.15%374,646 | $1.69 | $42,250 | View SEC filing | |
| 2024-11-14 | Maynard Ryan D Director | Sale | -50,000 | -86.96%7,500 | $10.06 | $503,000 | View SEC filing | |
| 2024-02-20 | MCPEAK MERRILL A Director | Purchase | +250,000 | +356.38%320,150 | $9.15 | $2,287,500 | View SEC filing | |
| 2024-02-20 | Dukes Iain D. Director | Purchase | +32,000 | +145.45%54,000 | $9.15 | $292,800 | View SEC filing | |
| 2024-02-20 | Rothbaum Wayne P. Director | Purchase | +5,000,000 | +21.68%28,067,333 | $9.15 | $45,750,000 | View SEC filing | |
| 2023-09-19 | MCPEAK MERRILL A Director | Purchase | +10,000 | +4.19%248,633 | $5.56 | $55,600 | View SEC filing | |
| 2023-09-15 | Rothbaum Wayne P. Director | Purchase | +5,000,000 | +27.67%23,067,333 | $5.30 | $26,500,000 | View SEC filing | |
| 2022-12-22 | MCPEAK MERRILL A Director | Purchase | +10,000 | +16.63%70,150 | $6.15 | $61,500 | View SEC filing | |
| 2022-12-02 | Rothbaum Wayne P. Director | Purchase | +10,000,000 | +123.96%18,067,333 | $6.50 | $65,000,000 | View SEC filing | |
| 2022-11-30 | MCPEAK MERRILL A Director | Purchase | +10,000 | +4.37%238,633 | $6.31 | $63,100 | View SEC filing | |
| 2022-11-28 | Vogt Frederick G Interim CEO & General Counsel | Purchase | +1,000 | +100.00%2,000 | $5.98 | $5,980 | View SEC filing | |
| 2022-11-28 | MCPEAK MERRILL A Director | Purchase | +10,000 | +4.57%228,633 | $6.18 | $61,800 | View SEC filing | |
| 2022-11-28 | Dukes Iain D. Director | Purchase | +10,000 | +83.33%22,000 | $6.10 | $61,000 | View SEC filing | |
| 2022-06-02 | MCPEAK MERRILL A Director | Purchase | +20,000 | +9.14%238,783 | $6.82 | $136,400 | View SEC filing | |
| 2022-06-02 | Maynard Ryan D Director | Purchase | +7,500 | +100.00%7,500 | $6.75 | $50,588 | View SEC filing | |
| 2022-06-02 | WEISER MICHAEL Director | Purchase | +10,000 | +9.74%112,632 | $6.80 | $67,978 | View SEC filing | |
| 2022-06-02 | Vogt Frederick G Interim CEO & General Counsel | Purchase | +1,000 | +100.00%1,000 | $6.44 | $6,440 | View SEC filing | |
| 2022-06-02 | Rothbaum Wayne P. Director | Purchase | +1,000,000 | +14.15%8,067,333 | $6.60 | $6,600,050 | View SEC filing | |
| 2018-12-20 | Dukes Iain D. Director | Purchase | +12,000 | +100.00%12,000 | $8.65 | $103,796 | View SEC filing | |
| 2018-12-14 | MCPEAK MERRILL A Director | Purchase | +10,000 | +2.24%456,583 | $9.63 | $96,273 | View SEC filing | |
| 2018-12-07 | Rothbaum Wayne P. Director | Purchase | +1,221,053 | +20.89%7,067,333 | $10.20 | $12,454,056 | View SEC filing | |
| 2016-08-26 | Hillsberg Sanford Director | Sale | -54,000 | -35.06%100,000 | $8.95 | $483,412 | View SEC filing | |
| 2016-08-24 | Hillsberg Sanford Director | Sale | -54,000 | -35.06%100,000 | $9.11 | $491,740 | View SEC filing |
1-25 of 34